Q3 2019 Holdings
Filed 2019-11-12 | 33 holdings | $966.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-01-03) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spark Therapeutics Inc | COM | 84652J103 | $83.7M | 863,300 | 8.7% |
| Invitae Corp(NVTA1EUR)A | COM | 46185L103 | $74.0M | 3,838,388 | 7.7% |
| Codexis Inc(CDXS)A | COM | 192005106 | $69.6M | 5,073,780 | 7.2% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $69.1M | 940,000 | 7.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $66.3M | 880,000 | 6.9% |
| Myokardia Inc | COM | 62857M105 | $58.1M | 1,115,000 | 6.0% |
| Bluebird BIO Inc | COM | 09609G100 | $56.2M | 612,500 | 5.8% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $56.1M | 400,000 | 5.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $48.3M | 600,000 | 5.0% |
| Biolife Solutions Inc(BLFS)A | COM | 09062W204 | $40.4M | 2,428,571 | 4.2% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $39.6M | 2,550,000 | 4.1% |
| Magenta Therapeutics IncA | COM | 55910K108 | $31.3M | 3,048,121 | 3.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $30.3M | 935,000 | 3.1% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $24.2M | 860,000 | 2.5% |
| Caredx Inc(CDNA) | COM | 14167L103 | $22.6M | 1,000,000 | 2.3% |
| Genmark Diagnostics Inc(GNMK)A | COM | 372309104 | $20.4M | 3,365,000 | 2.1% |
| Voyager Therapeutics Inc(VYGR)A | COM | 92915B106 | $19.4M | 1,128,075 | 2.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $18.3M | 60,000 | 1.9% |
| Gritstone Oncology Inc(2JQ)A | COM | 39868T105 | $15.3M | 1,770,000 | 1.6% |
| Homology Medicines Inc | COM | 438083107 | $14.8M | 820,000 | 1.5% |
| Global Blood Therapeutics in | COM | 37890U108 | $14.6M | 300,000 | 1.5% |
| Adaptive Biotechnologies COR(ADPT)A | COM | 00650F109 | $14.3M | 463,125 | 1.5% |
| Sangamo Therapeutics Inc(SGMO)A | COM | 800677106 | $13.2M | 1,455,000 | 1.4% |
| Alector Inc(ALEC) | COM | 014442107 | $11.7M | 811,039 | 1.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $10.0M | 650,000 | 1.0% |
| Constellation Pharmceticls I(CNST)A | COM | 210373106 | $9.8M | 1,523,960 | 1.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $9.4M | 415,000 | 1.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $7.2M | 300,000 | 0.7% |
| Fulcrum Therapeutics Inc(FULC)A | COM | 359616109 | $5.6M | 844,285 | 0.6% |
| Orchard Therapeutics PLC | ADR | 68570P101 | $3.7M | 310,000 | 0.4% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $3.4M | 100,000 | 0.4% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.8M | 75,000 | 0.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.8M | 130,000 | 0.3% |